Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 36 pages
Exam (elaborations)

New Jersey Drug Safety and Pharmacovigilance Certification Exam Questions and Correct Answers | Adverse Event Reporting, Signal Detection, Risk Management & Drug Safety Compliance Guide

Document preview thumbnail
Preview 4 out of 36 pages

Prepare for the New Jersey Drug Safety and Pharmacovigilance Certification Exam with this comprehensive collection of exam-style questions and correct answers. This study guide covers pharmacovigilance principles, adverse event reporting, Individual Case Safety Reports (ICSRs), signal detection, risk management plans, benefit-risk assessment, post-marketing surveillance, MedDRA coding, pharmacoepidemiology, FDA and EMA regulations, ICH guidelines, aggregate safety reporting, safety data analysis, pharmacovigilance audits, CAPA, safety management systems, and global drug safety compliance. It is designed for drug safety associates, pharmacovigilance specialists, regulatory affairs professionals, clinical research personnel, quality professionals, and pharmaceutical industry candidates seeking certification success and career advancement. Drug safety and pharmacovigilance programs commonly emphasize adverse event management, signal detection, risk mitigation, regulatory reporting, and patient safety throughout the product lifecycle.

Content preview

New Jersey Drug Safety And
Pharmacovigilance Certification Exam
Question and correct
answers (verified answers 100%) Q&A
2026/2027 INSTANT DOWNLOAD PDF


1. What is the primary purpose of pharmacovigilance?
A. To increase drug sales
B. To detect, assess, understand, and prevent adverse drug reactions
C. To develop marketing campaigns
D. To reduce manufacturing costs
Correct Answer: B
Rationale: Pharmacovigilance focuses on detecting, assessing, understanding, and
preventing adverse effects or other drug-related problems to improve patient
safety.


2. Which term refers to an unwanted and harmful reaction occurring at normal
drug doses?
A. Therapeutic effect
B. Adverse Drug Reaction (ADR)
C. Indication
D. Contraindication

,Correct Answer: B
Rationale: An ADR is a harmful and unintended response to a medicinal product
used at normal doses.


3. Which federal program allows healthcare professionals and consumers to
report adverse drug events?
A. Medicare
B. Medicaid
C. FDA MedWatch
D. DEA Watch
Correct Answer: C
Rationale: FDA MedWatch is the national reporting system for adverse events and
product safety concerns.


4. What does ICSR stand for in pharmacovigilance?
A. International Clinical Safety Report
B. Individual Case Safety Report
C. Integrated Case Study Record
D. Internal Clinical Surveillance Review
Correct Answer: B
Rationale: An ICSR is the standard format used to document and report adverse
event cases.


5. Which phase of a drug's lifecycle relies heavily on post-marketing
surveillance?
A. Discovery
B. Preclinical Research

,C. Phase I Trials
D. Post-Approval Marketing
Correct Answer: D
Rationale: Post-marketing surveillance monitors drug safety after approval when
larger populations use the product.


6. What is the primary goal of signal detection?
A. Increase prescriptions
B. Identify potential new safety concerns
C. Improve packaging
D. Reduce clinical trials
Correct Answer: B
Rationale: Signal detection identifies patterns suggesting possible new risks
associated with a drug.


7. Which organization defines pharmacovigilance globally?
A. CDC
B. WHO
C. DEA
D. NIH
Correct Answer: B
Rationale: The World Health Organization provides internationally accepted
definitions and guidance for pharmacovigilance.


8. Which of the following is considered a serious adverse event (SAE)?

, A. Mild headache
B. Temporary nausea
C. Hospitalization
D. Dry mouth
Correct Answer: C
Rationale: Events causing hospitalization, death, disability, or life-threatening
conditions are classified as serious.


9. What is the purpose of risk management plans (RMPs)?
A. Increase revenue
B. Minimize and monitor drug risks
C. Eliminate competitors
D. Reduce labeling requirements
Correct Answer: B
Rationale: RMPs identify, evaluate, and minimize risks associated with medicinal
products.


10. Which source is commonly used for spontaneous adverse event reporting?
A. Healthcare professionals
B. Marketing agencies
C. Insurance brokers
D. Product suppliers
Correct Answer: A
Rationale: Healthcare professionals are major contributors to spontaneous safety
reporting systems.


11. What does causality assessment determine?

Document information

Uploaded on
August 15, 2026
Number of pages
36
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$23.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
2
Followers
0
Items
924
Last sold
4 days ago


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions